AHRQ Safety Program for Improving Antibiotic Use

One approach may be to administer an agent like cefepime or piperacillin-tazobactam as empiric therapy for suspected cases of VAP with the addition of an aminoglycoside or ciprofloxacin for severely ill patients, patients who recently received either cefepime or piperacillin-tazobactam, or patients who previously had gram-negative organisms ... ................
................